SCHEDULE: Brandes Investment Partners Discloses 7.39% Stake
Beneficial Ownership Report
Brandes Investment Partners, L.P. has disclosed a 7.39% beneficial ownership stake in Utah Medical Products Inc. common shares.
Summary
- Brandes Investment Partners, L.P. reported beneficial ownership of 271,537 common shares of Utah Medical Products Inc.
- This ownership represents 7.39% of the issuer's common shares outstanding.
- The reporting person, Brandes Investment Partners, L.P., holds shared voting and shared dispositive power over all 271,537 shares.
- Brandes Investment Partners, L.P. is classified as an investment adviser.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: The disclosure of a significant passive stake by a reputable investment firm can be viewed as a positive signal of investor confidence, though the filing itself contains no operational or financial performance data.
Positives
- A significant stake by Brandes Investment Partners, L.P., a recognized investment adviser, may signal confidence in Utah Medical Products Inc.
- The investment is stated to be for ordinary course of business, not for control, suggesting a passive, long-term investment perspective.
Negatives
- No specific negative information about Utah Medical Products Inc. is disclosed in this ownership filing.
Risks
- The filing itself does not detail specific risks related to Utah Medical Products Inc.'s operations or financial health; it is a disclosure of ownership.
Future Outlook
Not applicable as this filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from the issuer.
Industry Context
This filing indicates a significant institutional investment in the medical products sector, reflecting ongoing investor interest in companies like Utah Medical Products Inc. within the healthcare industry.
Stakeholder Impact
- Shareholders: Increased institutional ownership may provide stability and potentially attract further investor interest.
- Management: Awareness of a significant passive shareholder, though not intended to influence control.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event requiring the filing of this statement. |
| 08/11/2025 | Signature date of the filing by Brandes Investment Partners, LP. |
Keywords
Utah Medical Products Inc., Brandes Investment Partners, Beneficial Ownership, Common Shares, SEC Filing, Schedule 13G, Investment Adviser, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.